Literature DB >> 7306972

Potency of some carbamates as multiple tissue sister chromatid exchange inducers and comparison with known carcinogenic activities.

M Cheng, M K Conner, Y Alarie.   

Abstract

The ethyl, ethyl N-hydroxy, isopropyl, and methyl esters of carbamic acid were examined for their abilities to induce sister chromatid exchanges (SCEs) in alveolar macrophages, bone marrow, and regenerating liver cells of C57BL/6J X DBA/2J F1 mice. The relative potencies in inducing SCE, ethyl greater than ethyl N-hydroxy- greater than isopropyl, paralleled previously described activities for induction of lung adenomas in strain A mice. The noncarcinogenic methyl carbamate was inactive in the SCE assay. Relative to bone marrow, regenerating liver and alveolar macrophage cells demonstrated increased susceptibility to carbamate-induced SCE. Of all carbamates studied, only the directly active compound, ethyl N-hydroxycarbamate, produced distinctly different responses in extrahepatic tissues of hepatectomized and intact mice. In intact mice, SCE levels induced by ethyl carbamate in bone marrow and alveolar macrophage cells were not significantly different whether assay followed the last of 12 (three times weekly) serial injections of 2.2 mmol/kg each or after a single injection of 2.2 mmol/kg. Linear regression relationships of log ethyl carbamate versus log SCE or log adenoma response were found to be parallel with the two assays having similar sensitivities.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306972

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Sister chromatid exchange analysis in cultured primary lung, liver, and kidney cells of mice following in vivo exposure to vinyl carbamate.

Authors:  J A Campbell; C F Eppersimons; A D Kligerman; A B Petro; Y Sharief; J W Allen
Journal:  In Vitro Cell Dev Biol       Date:  1986-08

2.  Liver carcinogenesis by methyl carbamate in F344 rats and not in B6C3F1 mice.

Authors:  P C Chan; J Huff; J K Haseman; J A Quest; W Hall
Journal:  Jpn J Cancer Res       Date:  1992-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.